Chapter 2 Gene Editing Therapeutics Market (BIO259A)
- Scope of Report of Gene Editing Therapeutics
- Market Outlook of Gene Editing Therapeutics
- Market Summary
- Market Overview of Gene Editing Therapeutics
- Genome-Editing Tool Types
- Meganucleases
- Zinc Finger Nucleases
- Transcription Activator-like Effector Nucleases
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-Associated Protein 9
- Gene editing Therapeutics
- Market Dynamics of Gene Editing Therapeutics
- Market Driver
- Market Challenges
- Emerging Technologies and Opportunities of Gene Editing Therapeutics
- Base Editing
- Prime Editing
- Cas-Clover and Cas-FOKl
- CRISPR Interference and CRISPR Activation
- RNA Editing
- Artificial Intelligence in Genome Editing
- Market Analysis of Gene Editing Therapeutics
- Overview
- Casgevy
- Market of Gene Editing Therapeutics by Region
- North America
- Europe
- Emerging Markets
- ESG Performance in Gene Editing Therapeutics Market
- ESG Practices in the Gene Editing Companies
- Concluding Remarks
Chapter 3 Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
- Scope of Report of DNA Sequencing: Research, Applied and Clinical Markets
- Market Outlook of DNA Sequencing: Research, Applied and Clinical Markets
- Market Summary of DNA Sequencing: Research, Applied and Clinical Markets
- Market Overview of DNA Sequencing: Research, Applied and Clinical Markets
- Importance of DNA
- Genetic Variation and Analysis
- NGS (Second-generation Sequencing)
- TGS (Long-read Sequencing)
- Research and Applied Applications
- R&D Applications
- Applied Applications
- Direct to Consumer
- Biopharma
- Agriculture
- Forensics
- Microbiome
- Synthetic Biology
- Market Dynamics of DNA Sequencing: Research, Applied and Clinical Markets
- Market Driver
- Market Restraint
- Emerging Technologies of DNA Sequencing: Research, Applied and Clinical Markets
- Long-read Sequencing Technologies
- SMRT Sequencing
- Nanopore Sequencing
- Spatial Genomics and Transcriptomics
- Single-cell DNA Sequencing
- Ultra-low Input Sequencing
- CRISPR-Cas9 and Genome-editing Integration with Sequencing Technologies
- AI and Machine Learning in DNA Sequencing
- Market Breakdown of DNA Sequencing: Research, Applied and Clinical Markets by Technology
- Overview
- NGS
- TGS
- Sanger Sequencing
- Pyrosequencing
- Market Breakdown of DNA Sequencing: Research, Applied and Clinical Markets by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- ESG Performance in DNA Sequencing Industry
- Environmental Performance
- Social Performance
- Governance Performance
- ESG Risk Ratings in the DNA Sequencing Industry
- Concluding Remarks
Chapter 4 Next-generation Sequencing: Emerging Clinical Applications and Global Markets (BIO126E)
- Scope of Report of Next-generation Sequencing
- Market Outlook of Next-generation Sequencing
- Market Summary of Next-generation Sequencing
- Market Overview of Next-generation Sequencing
- Liquid and Tissue Biopsy
- Growth Drivers of Clinical NGS
- Key Trends
- Market Dynamics of Next-generation Sequencing
- Market Driver
- Market Restraint
- Emerging Technologies of Next-generation Sequencing
- R&D Initiatives and Programs
- 1+ Million Genomes
- Access to Treatment and Testing (ACTT)
- Access to Comprehensive Genomic Profiling Coalition (ACGP)
- Africa Pathogen Genomics Initiative
- Blood Profiling Atlas
- Cancer-ID
- Cancer Moon Shots Program
- China Precision Medicine Initiative
- ClinGen
- CTC Trap Consortium
- diaRNAgnosis Project
- Early Cancer Detection Consortium
- EpiFemCare
- France Genomic Medicine Plan
- Friends of Cancer Research Project
- Genomic Medicine Sweden
- HCA-Organoid
- Human Cell Atlas
- Human Immunomics Initiative
- Immunomonitor Consortium
- Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy Program
- Intervene
- Liquid Biopsies and Imaging for Improved Cancer Care
- Liquid Biopsy-Based Malignant Tumor Early Screening Technology Research and Development Project
- Liver Cancer Early Screening Comprehensive Prevention and Control Project
- Lung Cancer Genomic Screening Project for Individualized Medicine in Asia
- Million Veteran Program
- Medical Genome Initiative
- MedSeq
- Market Breakdown of Next-generation Sequencing by Disease Category
- Overview
- Market Breakdown of Next-generation Sequencing by Region
- North America
- Europe
- Asia-Pacific
- ESG Performance in Next-generation Sequencing Industry
- Case Study
- BCC Research Viewpoint
Chapter 5 RNA Sequencing: Technologies and Global Markets (BIO147B)
- Scope of Report of RNA Sequencing
- Market Outlook of RNA Sequencing
- Market Summary of RNA Sequencing
- Market Overview of RNA Sequencing
- Technology Background
- Transcriptomics Technologies
- RNA Sequencing for Transcriptomics
- RNA-Seq Experimental Workflow
- Regulatory Landscape of RNA Sequencing
- Growth Strategy Recommendations
- Market Dynamics of RNA Sequencing
- Market Drivers
- Market Restraints
- Market Opportunity
- Emerging Technologies and Developments of RNA Sequencing Market
- Single-Cell RNA Sequencing
- Other Emerging Single-Cell Technologies
- Market Breakdown of RNA Sequencing by Product
- Instruments
- Tools and Reagents
- Software and Services
- Market Breakdown of RNA Sequencing by Region
- Overview
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Sustainability in RNA Sequencing Market: ESG Perspective
- ESG Practices in the RNA Sequencing Industry
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks
Chapter 6 RNAi Technologies and Global Markets ( BIO127C)
- Scope of Report of RNAi Technologies
- Market Snapshot of RNAi Technologies
- Market Summary of RNAi Technologies
- Market Overview of RNAi Technologies
- RNA Interference Overview
- RNA Interference: Mechanism of Action
- Initiation Phase
- Effector Phase
- Small Interfering RNAs (siRNAs)
- MicroRNAs (miRNAs)
- Small Hairpin RNAs (shRNAs)
- Market Dynamics of RNAi Technologies
- Market Drivers
- Market Challenges
- Emerging Technologies and Opportunities of RNAi Technologies
- Therapeutics
- Diagnostics
- Circulating miRNA Diagnostics for Non-invasive Health Monitoring
- Agriculture
- Market for RNAi Technology by Technology
- Therapeutics
- Diagnostics
- Reagents and Tools
- Agriculture
- Market for RNAi Technology by Region
- Overview
- North America
- Europe
- Emerging Markets
- Sustainability in RNAi Technology Industry: An ESG Perspective
- Environmental Initiatives
- Social Initiatives
- Governance Initiatives
- Case Study
- Concluding Remarks
Chapter 7 Viral Vector and Plasmid DNA: Technologies and Global Markets (BIO192B)
- Scope of Report of Viral Vector and Plasmid DNA
- Market Outlook of Viral Vector and Plasmid DNA
- Market Summary of Viral Vector and Plasmid DNA
- Market Overview of Viral Vector and Plasmid DNA
- Cell and Gene Therapy
- Market Dynamics of Viral Vector and Plasmid DNA
- Market Driver
- Market Challenges
- Emerging Technologies and Opportunities of Viral Vector and Plasmid DNA
- AI in Viral Vector Production
- Doggybone DNA
- FRAGment Recycler: A New Technology for Plasmid DNA Synthesis
- Market for Viral Vector and Plasmid DNA Technologies by Product Type
- Market for Viral Vector and Plasmid DNA Technologies by Application
- Market for Viral Vector and Plasmid DNA Technologies by Region
- Overview
- North America
- Europe
- Asia-Pacific
- Latin America
- Rest of the World
- Sustainability in the Market for Viral Vector and Plasmid DNA Technologies: An ESG Perspective
- Environmental Factors
- Social Factors
- Governance Factors
- ESG Performance Among Major Companies
- ESG Performance of Select Companies
- Lonza: ESG Performance
- Thermo Fisher: ESG Performance
- Conclusion
List of Tables
Table 1: Global Market for Gene Editing Therapeutics, Through 2029
Table 2: Comparison of Genome-Editing Tools
Table 3: U.S. Adults Age 50 Years and Older with Multiple Chronic Conditions, 2020-2050
Table 4: Global Cases and Deaths Due to Various Cancers, 2022
Table 5: Comparison of Cas9-derived Proteins with Regular SpCas9
Table 6: Global Market for Gene Editing Therapeutics, Through 2029
Table 7: Global Market for Gene Editing Therapeutics, by Region, Through 2029
Table 8: ESG Initiatives/Practices by Various Gene Editing Companies, 2023
Table 9: ESG Rankings for Companies in the Gene Editing Therapeutics Market, 2023
Table 10: Global DNA Sequencing Market, by Region, Through 2029
Table 11: DNA Transcription and Translation
Table 12: Types of Genetic Variation
Table 13: Molecular Diagnostic Technology Platforms
Table 14: Main Sequencing Applications
Table 15: Genetic Analysis Platform Comparison
Table 16: Key Applications in Microbial Sequencing
Table 17: Global DNA Sequencing Market, by Technology, Through 2029
Table 18: Different Generations of NGS Platforms
Table 19: Global DNA Sequencing Market, by Region, Through 2029
Table 20: Environmental Performance Initiatives in the DNA Sequencing Market
Table 21: Social Performance Initiatives in the DNA Sequencing Market
Table 22: Governance Performance Initiatives in the DNA Sequencing Market
Table 23: ESG Rankings for Key Players in DNA Sequencing Market, 2024*
Table 24: Global Market for Clinical Applications of Next-Generation Sequencing, by Disease Class, Through 2028
Table 25: Forces Influencing Growth in the Clinical NGS Market
Table 26: Key Trends in the Clinical NGS Testing Market
Table 27: Future Challenges in Implementing Clinical NGS
Table 28: Clinical NGS Research and Development Initiatives and Programs
Table 29: Global Market for Clinical NGS, by Disease Category, Through 2028
Table 30: Global Market for Clinical NGS, by Region, Through 2028
Table 31: Key Focus Areas in ESG Metrics
Table 32: ESG Rankings for Major Companies in the NGS Arena
Table 33: Illumina 2030 ESG Targets
Table 34: Global Market for RNA Sequencing, by Product, Through 2029
Table 35: Global Market for RNA Sequencing, by Technology, Through 2029
Table 36: Types of RNAs in Cells
Table 37: Comparison of Transcriptomics Methods
Table 38: Functional Elements in Sequencing Adapters
Table 39: Overview of Illumina’s Sequencing Instruments
Table 40: Cloud Computing Providers for Genomics/RNA-Seq
Table 41: Global Market for RNA Sequencing, by Region, Through 2029
Table 42: Research Initiatives Focused on Personalized Medicine in Europe
Table 43: Key Focus Areas in ESG Metrics
Table 44: Environmental Performance Initiatives in the RNA Sequencing Market
Table 45: Social Performance Initiatives in the RNA Sequencing Market
Table 46: Governance Performance Initiatives in the RNA Sequencing Market
Table 47: ESG Rankings for Key Players in RNA Sequencing Market, 2024*
Table 48: Global Market for RNAi Technology, by Technology Type, Through 2029
Table 49: Cost Comparison of siRNA-approved Drugs and Alternative Therapies
Table 50: Global Market for RNAi Technology, by Technology Type, Through 2029
Table 51: RNAi Approved Drugs List
Table 52: miRNA-based Diagnostic Tools Available in Clinical Settings
Table 53: Global Market for RNAi Technology, by Region, Through 2029
Table 54: Key Focus Areas in ESG Metrices
Table 55: Environmental Initiatives, by Various RNAi Technology Companies
Table 56: ESG Rankings for Companies in the RNAi Technology Market, 2023
Table 57: Alnylam’s ESG initiatives
Table 58: Global Market for Viral Vector and Plasmid DNA Technologies, by Product Type, Through 2028
Table 59: Global Incidence of All Cancers, by WHO Region, 2022-2050
Table 60: Global Market for Viral Vector and Plasmid DNA Technologies, Through 2028
Table 61: Global Market for Viral Vector and Plasmid DNA Technologies, by Product Type, Through 2028
Table 62: Global Market for Viral Vector and Plasmid DNA Technologies, by Application, Through 2028
Table 63: Global Market for Viral Vector and Plasmid DNA Technologies, by Region, Through 2028
Table 64: ESG Rankings of Major Companies, 2024*
Table 65: Lonza: ESG Performance
Table 66: Thermo Fisher: ESG Performance
List of Figures
Figure 1: Global Market for Gene Editing Therapeutics, 2021-2029
Figure 2: Emerging Technologies in the Genome-Editing Therapeutics Market
Figure 3: Global DNA Sequencing Market Shares, by Region, 2023
Figure 4: Global Market Shares of DNA Sequencing, by Technology, 2023
Figure 5: Global DNA Sequencing Market Shares, by Region, 2023
Figure 6: Global Market for Clinical Applications of Next-Generation Sequencing, by Disease Class, 2020-2028
Figure 7: Key Sustainable Practices Being Implemented in Research Laboratories
Figure 8: Global Market for RNA Sequencing, by Product, 2021-2029
Figure 9: Global Market for RNA Sequencing, by Technology, 2021-2029
Figure 10: RNA-Seq Experiments for Transcriptomics
Figure 11: RNA-Seq Experimental Workflow
Figure 12: Growth Strategy Recommendations: RNA Sequencing Market
Figure 13: Average Cost Per Genome: Y-o-Y Trend, 2011-2022
Figure 14: Global Market Shares of RNA Sequencing, by Product, 2024
Figure 15: Global Market Shares of RNA Sequencing, by Region, 2024
Figure 16: Growth Drivers in Asia-Pacific RNA Sequencing Market
Figure 17: Global Market for RNAi Technology, by Technology Type, 2021-2029
Figure 18: Global Market Shares of RNAi Technology, by Technology Type, 2023
Figure 19: Global Market for RNAi Technology, by Region, 2021-2029
Figure 20: Global Market Shares of RNAi Technology, by Region, 2023
Figure 21: Global Market for Viral Vector and Plasmid DNA Technologies, by Product Type, 2020-2028
Figure 22: Global Market Shares of Viral Vector and Plasmid DNA Technologies, by Product Type, 2022
